148 related articles for article (PubMed ID: 7074957)
1. Effect of contraceptive steroids on creatine kinase activity in serum.
Gupta U; Gupta RC
Clin Chem; 1982 Jun; 28(6):1402-3. PubMed ID: 7074957
[No Abstract] [Full Text] [Related]
2. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
Ayangade O; Akinyemi A
Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
[TBL] [Abstract][Full Text] [Related]
3. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
4. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
Rangnekar KN; Rao SS; Joshi UM
Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
[TBL] [Abstract][Full Text] [Related]
5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
6. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
Johansson ED; Elamsson K; Elmestedt U
Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
[No Abstract] [Full Text] [Related]
7. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
8. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
[TBL] [Abstract][Full Text] [Related]
12. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
El Hakim SM; Abdin FH; Kandil O
Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
14. Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins.
Taggart H; Stout RW
Ir J Med Sci; 1981 Jan; 150(1):13-4. PubMed ID: 7216711
[No Abstract] [Full Text] [Related]
15. Hormonal steroids: effects on the vascular system.
Solash J; Perez R; Keates JS; Ramasamy N; Stein H; Troyansky D; Ateyeh E; Jones JR; Srinivasan S; Sawyer PN
Gynecol Invest; 1975; 6(6):329-36. PubMed ID: 1213600
[TBL] [Abstract][Full Text] [Related]
16. Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
Elwan O; Madkour O; Kamal I; Abdallah M
J Int Med Res; 1973; 1(6):534-47. PubMed ID: 4806735
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral contraceptive agents on copper and zinc balance in young women.
Crews MG; Taper LJ; Ritchey SJ
Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
[TBL] [Abstract][Full Text] [Related]
19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
20. A crossover pill study among Sudanese women.
Gerais AS; Rushwan H
Int J Gynaecol Obstet; 1985 Jun; 23(3):229-33. PubMed ID: 2865187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]